Stay updated with breaking news from Remunity Pump. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Assetmark Inc. grew its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 12.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 270,423 shares of the biotechnology company’s stock after acquiring an additional 30,060 shares during the period. Assetmark Inc. owned […]
United Therapeutics (NASDAQ:UTHR – Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported $5.24 earnings per share for the quarter, topping analysts’ consensus estimates of $4.57 by $0.67, MarketWatch Earnings reports. United Therapeutics had a return on equity of 18.05% and a net margin of 41.29%. The firm had revenue […]
Presentation Operator MessageOperator Good morning, and welcome to the United Therapeutics Corporation Second Quarter 2023 Earnings Webcast. My name is Danielle, and I will be your conference operator...
Premier Fund Managers Ltd reduced its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 12.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,000 shares of the biotechnology company’s stock after selling 3,000 shares during the […]
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation and seven have issued a buy recommendation on the company. The average 12 […]